These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33662472)

  • 1. Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation.
    Gonzalez-Valdivieso J; Girotti A; Schneider J; Arias FJ
    Int J Pharm; 2021 Apr; 599():120438. PubMed ID: 33662472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
    Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionanomedicine: Advanced Strategy for Precision Theranostics of Breast Cancer.
    Guo Y; Liu X
    J Biomed Nanotechnol; 2022 Jan; 18(1):50-60. PubMed ID: 35180899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoinformatics and Personalized Medicine: An Advanced Cumulative Approach for Cancer Management.
    Khan F; Akhtar S; Kamal MA
    Curr Med Chem; 2023; 30(3):271-285. PubMed ID: 35692148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic nanoparticles for the management of thrombosis.
    Russell P; Hagemeyer CE; Esser L; Voelcker NH
    Theranostics; 2022; 12(6):2773-2800. PubMed ID: 35401833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostics - a sure cure for cancer after 100 years?
    Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X
    Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles in Clinical Translation for Cancer Therapy.
    Mundekkad D; Cho WC
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining gene therapy with other therapeutic strategies and imaging agents for cancer theranostics.
    Azevedo A; Farinha D; Geraldes C; Faneca H
    Int J Pharm; 2021 Sep; 606():120905. PubMed ID: 34293466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nanomedicine : Magnetic nanoparticles for drug delivery and hyperthermia - new chances for cancer therapy].
    Alexiou C; Tietze R; Schreiber E; Lyer S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):839-45. PubMed ID: 20700784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanodrugs used in cancer therapy.
    Kopeckova K; Eckschlager T; Sirc J; Hobzova R; Plch J; Hrabeta J; Michalek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):122-131. PubMed ID: 30967685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Metal-Phenolic Networks for Cancer Theranostics.
    Zhang Z; Xie L; Ju Y; Dai Y
    Small; 2021 Oct; 17(43):e2100314. PubMed ID: 34018690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
    Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
    Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
    Ganipineni LP; Danhier F; Préat V
    J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision.
    Sahakyan N; Haddad A; Richardson S; Forcha-Etieundem V; Christopher L; Alharbi H; Campbell R
    Anticancer Agents Med Chem; 2017; 17(8):1033-1039. PubMed ID: 28042778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.